AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
VITRAVENE(TM) - ANOTHER PIECE IN THE MOSAIC
Authors: CROOKE ST
Citation: St. Crooke, VITRAVENE(TM) - ANOTHER PIECE IN THE MOSAIC, Antisense & nucleic acid drug development, 8(4), 1998, pp. 7-8
AN OVERVIEW OF PROGRESS IN ANTISENSE THERAPEUTICS
Authors: CROOKE ST
Citation: St. Crooke, AN OVERVIEW OF PROGRESS IN ANTISENSE THERAPEUTICS, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 8(2), 1998, pp. 115-122
MOLECULAR MECHANISMS OF ANTISENSE DRUGS - RNASE-H
Authors: CROOKE ST
Citation: St. Crooke, MOLECULAR MECHANISMS OF ANTISENSE DRUGS - RNASE-H, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 8(2), 1998, pp. 133-134
MOLECULAR-CLONING AND EXPRESSION OF CDNA FOR HUMAN RNASE-H
Authors: WU HJ LIMA WF CROOKE ST
Citation: Hj. Wu et al., MOLECULAR-CLONING AND EXPRESSION OF CDNA FOR HUMAN RNASE-H, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 8(1), 1998, pp. 53-61
ANTISENSE-98 - WORK-IN-PROGRESS
Authors: CROOKE ST ECKSTEIN F CHRISTOFFERSEN RE MEHTA V COTTER FE BENNETT CF AGRAWAL S HALLER H DORR FA GRINSTEAD EA
Citation: St. Crooke et al., ANTISENSE-98 - WORK-IN-PROGRESS, Nature biotechnology, 16(13), 1998, pp. 1319-1321
ANTISENSE THERAPY
Authors: CROOKE ST
Citation: St. Crooke, ANTISENSE THERAPY, Annals of oncology, 9, 1998, pp. 70-70
PROGRESS IN ANTISENSE THERAPEUTICS
Authors: CROOKE ST
Citation: St. Crooke, PROGRESS IN ANTISENSE THERAPEUTICS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 31-31
DEPLETION OF PROTEIN-KINASE-C-ALPHA BY ANTISENSE OLIGONUCLEOTIDES ALTERS BETA-ADRENERGIC FUNCTION AND REVERSES THE PHORBOL ESTER-INDUCED REDUCTION OF ISOPROTERENOL-INDUCED ADENOSINE 3'-5'-CYCLIC MONOPHOSPHATE ACCUMULATION IN MURINE SWISS 3T3 FIBROBLASTS
Authors: LEVESQUE L CROOKE ST
Citation: L. Levesque et St. Crooke, DEPLETION OF PROTEIN-KINASE-C-ALPHA BY ANTISENSE OLIGONUCLEOTIDES ALTERS BETA-ADRENERGIC FUNCTION AND REVERSES THE PHORBOL ESTER-INDUCED REDUCTION OF ISOPROTERENOL-INDUCED ADENOSINE 3'-5'-CYCLIC MONOPHOSPHATE ACCUMULATION IN MURINE SWISS 3T3 FIBROBLASTS, The Journal of pharmacology and experimental therapeutics, 287(1), 1998, pp. 425-434
IN-VIVO DISTRIBUTION AND METABOLISM OF A PHOSPHOROTHIOATE OLIGONUCLEOTIDE WITHIN RAT-LIVER AFTER INTRAVENOUS ADMINISTRATION
Authors: GRAHAM MJ CROOKE ST MONTEITH DK COOPER SR LEMONIDIS KM STECKER KK MARTIN MJ CROOKE RM
Citation: Mj. Graham et al., IN-VIVO DISTRIBUTION AND METABOLISM OF A PHOSPHOROTHIOATE OLIGONUCLEOTIDE WITHIN RAT-LIVER AFTER INTRAVENOUS ADMINISTRATION, The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 447-458
IDENTIFICATION AND PARTIAL-PURIFICATION OF HUMAN DOUBLE-STRAND RNASE ACTIVITY - A NOVEL TERMINATING MECHANISM FOR OLIGORIBONUCLEOTIDE ANTISENSE DRUGS
Authors: WU HJ MACLEOD AR LIMA WF CROOKE ST
Citation: Hj. Wu et al., IDENTIFICATION AND PARTIAL-PURIFICATION OF HUMAN DOUBLE-STRAND RNASE ACTIVITY - A NOVEL TERMINATING MECHANISM FOR OLIGORIBONUCLEOTIDE ANTISENSE DRUGS, The Journal of biological chemistry, 273(5), 1998, pp. 2532-2542
CONJUGATED ANTISENSE OLIGONUCLEOTIDES
Authors: MANOHARAN M TIVEL KL CONDON TP ANDRADE LK BARBERPEOCH I INAMATI G SHAH S MOHAN V GRAHAM MJ BENNETT CF CROOKE ST COOK PD
Citation: M. Manoharan et al., CONJUGATED ANTISENSE OLIGONUCLEOTIDES, Nucleosides & nucleotides, 16(7-9), 1997, pp. 1129-1138
PREFACE
Authors: CROOKE ST
Citation: St. Crooke, PREFACE, Anti-cancer drug design, 12(5), 1997, pp. 311-313
IMMUNE STIMULATION - A CLASS EFFECT OF PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES IN RODENTS
Authors: MONTEITH DK HENRY SP HOWARD RB FLOURNOY S LEVIN AA BENNETT CF CROOKE ST
Citation: Dk. Monteith et al., IMMUNE STIMULATION - A CLASS EFFECT OF PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES IN RODENTS, Anti-cancer drug design, 12(5), 1997, pp. 421-432
TOXICOLOGICAL PROPERTIES OF SEVERAL NOVEL OLIGONUCLEOTIDE ANALOGS IN MICE
Authors: HENRY SP ZUCKERMAN JE ROJKO J HALL WC HARMAN RJ KITCHEN D CROOKE ST
Citation: Sp. Henry et al., TOXICOLOGICAL PROPERTIES OF SEVERAL NOVEL OLIGONUCLEOTIDE ANALOGS IN MICE, Anti-cancer drug design, 12(1), 1997, pp. 1-14
ANTISENSE OLIGONUCLEOTIDES TARGETING HUMAN PROTEIN-KINASE C-ALPHA INHIBIT PHORBOL ESTER-INDUCED REDUCTION OF BRADYKININ-EVOKED CALCIUM MOBILIZATION IN A549 CELLS
Authors: LEVESQUE L DEAN NM SASMOR H CROOKE ST
Citation: L. Levesque et al., ANTISENSE OLIGONUCLEOTIDES TARGETING HUMAN PROTEIN-KINASE C-ALPHA INHIBIT PHORBOL ESTER-INDUCED REDUCTION OF BRADYKININ-EVOKED CALCIUM MOBILIZATION IN A549 CELLS, Molecular pharmacology, 51(2), 1997, pp. 209-216
CLEAVAGE OF SINGLE-STRAND RNA ADJACENT TO RNA-DNA DUPLEX REGIONS BY ESCHERICHIA-COLI RNASE H1
Authors: LIMA WF CROOKE ST
Citation: Wf. Lima et St. Crooke, CLEAVAGE OF SINGLE-STRAND RNA ADJACENT TO RNA-DNA DUPLEX REGIONS BY ESCHERICHIA-COLI RNASE H1, The Journal of biological chemistry, 272(44), 1997, pp. 27513-27516
THE INFLUENCE OF ANTISENSE OLIGONUCLEOTIDE-INDUCED RNA STRUCTURE ON ESCHERICHIA-COLI RNASE H1 ACTIVITY
Authors: LIMA WF MOHAN V CROOKE ST
Citation: Wf. Lima et al., THE INFLUENCE OF ANTISENSE OLIGONUCLEOTIDE-INDUCED RNA STRUCTURE ON ESCHERICHIA-COLI RNASE H1 ACTIVITY, The Journal of biological chemistry, 272(29), 1997, pp. 18191-18199
BINDING-AFFINITY AND SPECIFICITY OF ESCHERICHIA-COLI RNASE H1 - IMPACT ON THE KINETICS OF CATALYSIS OF ANTISENSE OLIGONUCLEOTIDE-RNA HYBRIDS
Authors: LIMA WF CROOKE ST
Citation: Wf. Lima et St. Crooke, BINDING-AFFINITY AND SPECIFICITY OF ESCHERICHIA-COLI RNASE H1 - IMPACT ON THE KINETICS OF CATALYSIS OF ANTISENSE OLIGONUCLEOTIDE-RNA HYBRIDS, Biochemistry, 36(2), 1997, pp. 390-398
PROGRESS IN THE DEVELOPMENT AND PATENTING OF ANTISENSE DRUG DISCOVERYTECHNOLOGY
Authors: CROOKE ST BERNSTEIN LS BOSWELL H
Citation: St. Crooke et al., PROGRESS IN THE DEVELOPMENT AND PATENTING OF ANTISENSE DRUG DISCOVERYTECHNOLOGY, Expert opinion on therapeutic patents, 6(9), 1996, pp. 855-870
PROOF OF MECHANISM OF ANTISENSE DRUGS
Authors: CROOKE ST
Citation: St. Crooke, PROOF OF MECHANISM OF ANTISENSE DRUGS, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 6(2), 1996, pp. 145-147
NEW DRUGS AND CHANGING DISEASE PARADIGMS - COMMENTARY ON DRUG DEVELOPMENT
Authors: CROOKE ST
Citation: St. Crooke, NEW DRUGS AND CHANGING DISEASE PARADIGMS - COMMENTARY ON DRUG DEVELOPMENT, Nature biotechnology, 14(3), 1996, pp. 238
THE FUTURE OF SEQUENCE-SPECIFIC TRANSCRIPTIONAL INHIBITION
Authors: CROOKE ST
Citation: St. Crooke, THE FUTURE OF SEQUENCE-SPECIFIC TRANSCRIPTIONAL INHIBITION, Cancer investigation, 14(1), 1996, pp. 89-90
PROGRESS IN ANTISENSE OLIGONUCLEOTIDE THERAPEUTIC
Authors: CROOKE ST BENNETT CF
Citation: St. Crooke et Cf. Bennett, PROGRESS IN ANTISENSE OLIGONUCLEOTIDE THERAPEUTIC, Annual review of pharmacology and toxicology, 36, 1996, pp. 107-129
PROGRESS IN ANTISENSE THERAPEUTICS
Authors: CROOKE ST
Citation: St. Crooke, PROGRESS IN ANTISENSE THERAPEUTICS, Medicinal research reviews, 16(4), 1996, pp. 319-344
PHARMACOKINETICS IN MICE OF A [H-3] LABELED PHOSPHOROTHIOATE OLIGONUCLEOTIDE FORMULATED IN THE PRESENCE AND ABSENCE OF A CATIONIC LIPID
Authors: BENNETT CF ZUCKERMAN JE KORNBRUST D SASMOR H LEEDS JM CROOKE ST
Citation: Cf. Bennett et al., PHARMACOKINETICS IN MICE OF A [H-3] LABELED PHOSPHOROTHIOATE OLIGONUCLEOTIDE FORMULATED IN THE PRESENCE AND ABSENCE OF A CATIONIC LIPID, Journal of controlled release, 41(1-2), 1996, pp. 121-130
Risultati: 1-25 | 26-43